Ra Capital Management, L.P. Werewolf Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $4.58 Billion
- Q2 2025
A detailed history of Ra Capital Management, L.P. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 6,681,307 shares of HOWL stock, worth $8.02 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
6,681,307
Previous 6,144,881
8.73%
Holding current value
$8.02 Million
Previous $5.96 Million
22.18%
% of portfolio
0.16%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding HOWL
# of Institutions
66Shares Held
23.6MCall Options Held
0Put Options Held
0-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.17 Million10.84% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.89 Million0.51% of portfolio
-
Bank Of America Corp Charlotte, NC2.13MShares$2.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$1.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$1.56 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $35.4M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...